First Case of A859T Epidermal Growth Factor Receptor Mutation Responding to Erlotinib

被引：6
|
作者：
Le Maignan, Laureline [1 ]
Mirebeau-Prunier, Delphine [2 ]
Vervueren, Laurent [3 ]
Jeanfaivre, Thierry [1 ]
Urban, Thierry [1 ]
Hureaux, Jose [1 ]
机构：
[1] Acad Hosp, Dept Pulmonol, F-49933 Angers, France
[2] Acad Hosp, Biochem & Mol Biol Lab, F-49933 Angers, France
[3] Acad Hosp, Dept Nucl Med, F-49933 Angers, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 03期
关键词：
CELL LUNG-CANCER; GEFITINIB; IMPACT;
D O I：
10.1097/JTO.0b013e3182037c0c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：639 / 640
页数：2
相关论文
共 50 条
  • [41] Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
    Haas-Kogan, DA
    Prados, MD
    Tihan, T
    Eberhard, DA
    Jelluma, N
    Arvold, ND
    Baumber, R
    Lamborn, KR
    Kapadia, A
    Malec, M
    Berger, MS
    Stokoe, D
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (12): : 880 - 887
  • [42] Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer
    Huether, Alexander
    Hoepfner, Michael
    Sutter, Andreas P.
    Baradari, Viola
    Schuppan, Detlef
    Scheruebl, Hans
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (32) : 5160 - 5167
  • [43] Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment
    Tan, A. R.
    Steinberg, S. M.
    Parr, A. L.
    Nguyen, D.
    Yang, S. X.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 185 - 190
  • [44] A review of erlotinib - an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor
    Iyer, Renuka
    Bharthuar, Anubha
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 311 - 320
  • [45] Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma
    Hayasaka, Kazuki
    Shiono, Satoshi
    Matsumura, Yuki
    Yanagawa, Naoki
    Suzuki, Hiroyuki
    Abe, Jiro
    Sagawa, Motoyasu
    Sakurada, Akira
    Katahira, Masato
    Takahashi, Satomi
    Endoh, Makoto
    Okada, Yoshinori
    ANNALS OF THORACIC SURGERY, 2018, 105 (06): : 1648 - 1654
  • [46] Effects of Erlotinib on Epidermal Growth Factor Receptor Signaling Pathway in Pancreatic Cancer Cells
    Liu, Lewei
    Zhou, Huanle
    Lin, Yuxin
    Wu, Suna
    Xu, Huanhai
    Chen, Weidong
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 294 - 298
  • [47] Activation of epidermal growth factor receptor by epidermal growth factor
    Sherrill, JM
    Kyte, J
    BIOCHEMISTRY, 1996, 35 (18) : 5705 - 5718
  • [48] An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases
    Tsuchiya, Kazuo
    Karayama, Masato
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    INTERNAL MEDICINE, 2018, 57 (23) : 3423 - 3427
  • [49] Epidermal growth factor receptor antagonistsParonychia: case report
    Reactions Weekly, 2022, 1918 (1) : 215 - 215
  • [50] Effect of epidermal growth factor receptor gene mutation on bevacizumab combined with erlotinib in the treatment of non-small cell lung cancer
    Yuan, Gao
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 5175 - 5178
12345